Header Logo

Connection

HELEN HESLOP to Vaccines, Synthetic

Back to Details
This is a "connection" page, showing publications HELEN HESLOP has written about Vaccines, Synthetic.
HELEN HESLOP
Connection Strength
0.012
Vaccines, Synthetic
  1. A strategy for treatment of Epstein-Barr virus-positive Hodgkin's disease by targeting interleukin 12 to the tumor environment using tumor antigen-specific T cells. Cancer Gene Ther. 2004 Feb; 11(2):81-91.
    View in: PubMed
    Score: 0.012
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.